As a consequence of migration, the prevalence of this disease in formerly non-prevalent countries is increasing [2]. Severe thalassemia requires blood transfusions followed by iron chelation therapy. The current palette of iron chelators includes potent deferoxamine, which needs frequent or continuous ...